These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 688739)

  • 1. Adenocarcinoma of the prostate.
    Von Eschenbach AC; Johnson DE
    Compr Ther; 1978 Aug; 4(8):18-26. PubMed ID: 688739
    [No Abstract]   [Full Text] [Related]  

  • 2. [Present status and questions on early prostatic cancer (stage A, B)].
    Oishi K; Arai Y; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1991 Aug; 37(8):789-93. PubMed ID: 1957722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cancer of the prostate with predominant lymphatic manifestation. Apropos of 2 cases].
    Herer B; Waligora J; Delfraissy JF; Dormont J
    J Urol (Paris); 1987; 93(8):475-7. PubMed ID: 3440840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difficult diagnostic and therapeutic cases: CASE 3. presentation of prostate cancer with cervical adenopathy.
    Gaur S; Aish LS; Oo TH
    J Clin Oncol; 2004 Mar; 22(5):957-8. PubMed ID: 14990654
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical conferences at the Johns Hopkins Hospital. Prostatic carcinoma.
    McPhee SJ; Katz RD; Olson JL; Walsh PC
    Johns Hopkins Med J; 1978 Dec; 143(6):207-11. PubMed ID: 723115
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oncologic after-care of patients with prostate cancer].
    Friedrich A; Glass W
    Z Urol Nephrol; 1986 Apr; 79(5):269-75. PubMed ID: 2426869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer: 2. Natural history.
    Nam RK; Jewett MA; Krahn MD
    CMAJ; 1998 Sep; 159(6):685-91. PubMed ID: 9780970
    [No Abstract]   [Full Text] [Related]  

  • 8. [Value of lymphography in the staging of prostatic cancer].
    Proca E; Zamfir V
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1978; 27(6):467-74. PubMed ID: 752848
    [No Abstract]   [Full Text] [Related]  

  • 9. Adenocarcinoma of the prostate.
    Swanson JO
    J Insur Med; 1997; 29(3):195-203. PubMed ID: 10176369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate carcinoma--the value of T stage and grade in predicting metastases and prognosis. A cost-effective approach to clinical staging.
    Allen FJ; de Kock ML; de Klerk DP; Heyns CF
    S Afr J Surg; 1991 Mar; 29(1):15-8. PubMed ID: 1905062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal management of prostatic cancer.
    Albertsen P; Marshall F
    Geriatrics; 1982 Dec; 37(12):69-72, 77-9. PubMed ID: 7141229
    [No Abstract]   [Full Text] [Related]  

  • 12. Pitfalls of retrospective and nonrandomized comparison of treatment modalities.
    Sandhu AP
    J Clin Oncol; 2010 Oct; 28(28):e520; author reply e521-e522. PubMed ID: 20660831
    [No Abstract]   [Full Text] [Related]  

  • 13. [The role of prostate-specific antigen in the diagnosis and treatment of prostatic adenocarcinoma].
    Stamey TA
    Urologe A; 1990 Mar; 29(2):52-64. PubMed ID: 1691883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staging evaluation for patients with adenocarcinoma of the prostate. American College of Radiology. ACR Appropriateness Criteria.
    Forman JD; Lee WR; Roach M; Perez CA; Beyer DC; Blasko JC; Hussey DH; Paryani SB; Pollack A; Potters L; Scardino P; Schellhammer P; Leibel S
    Radiology; 2000 Jun; 215 Suppl():1373-82. PubMed ID: 11037553
    [No Abstract]   [Full Text] [Related]  

  • 15. The management of localized prostate cancer.
    Clarke NW
    Br J Hosp Med; 1996 Mar 6-19; 55(5):232-3. PubMed ID: 8777510
    [No Abstract]   [Full Text] [Related]  

  • 16. [Management of a prostatic adenocarcinoma manifesting in stage C or D1 after prostatectomy].
    Guiter J; Constans JP; Nivard G; Iborra F; Rivet D; Averous M; Grasset D
    J Urol (Paris); 1987; 93(9-10):578. PubMed ID: 3443774
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cytoplasmic androgen and estrogen receptor content in the tissues of human prostatic cancer].
    Kushlinskiĭ NE; Bassalyk LS; Matveeva BP; Gorilovskiĭ LM; Degtiar' VG
    Urol Nefrol (Mosk); 1984; (4):41-6. PubMed ID: 6474626
    [No Abstract]   [Full Text] [Related]  

  • 18. Adenocarcinoma of the prostate gland.
    Finkelstein LH
    J Am Osteopath Assoc; 1983 Apr; 82(8):543-6. PubMed ID: 6853232
    [No Abstract]   [Full Text] [Related]  

  • 19. Total androgen suppression: are there any advantages? The use of combined therapy in the treatment of advanced prostate adenocarcinoma.
    Foote JE; Crawford ED
    Semin Urol; 1988 Nov; 6(4):291-302. PubMed ID: 3068767
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostatic carcinoma.
    Lawton CA; Grignon D; Newhouse JH; Schellhammer PF; Kuban DA
    Radiographics; 1999; 19(1):185-203. PubMed ID: 9925399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.